BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32851549)

  • 1. Dysphagia and respiratory failure in an HIV patient: MuSK myasthenia gravis.
    Wirtz PW
    Acta Neurol Belg; 2020 Dec; 120(6):1483-1484. PubMed ID: 32851549
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
    Yamada C; Teener JW; Davenport RD; Cooling L
    J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
    Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
    Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial autoimmune MuSK positive myasthenia gravis.
    Corda D; Deiana GA; Mulargia M; Pirastru MI; Serra M; Piluzza MG; Carcassi C; Sechi G
    J Neurol; 2011 Aug; 258(8):1559-60. PubMed ID: 21369718
    [No Abstract]   [Full Text] [Related]  

  • 5. Vocal cord paralysis in myasthenia gravis with anti-MuSK antibodies.
    Hara K; Mashima T; Matsuda A; Tanaka K; Tomita M; Shiraishi H; Motomura M; Nishizawa M
    Neurology; 2007 Feb; 68(8):621-2. PubMed ID: 17310039
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.
    Stein B; Bird SJ
    J Clin Neuromuscul Dis; 2011 Mar; 12(3):163-4. PubMed ID: 21321497
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-MuSK antibody positive myasthenia gravis with HIV infection successfully treated with cyclosporin: a case report].
    Kurokawa T; Nishiyama T; Yamamoto R; Kishida H; Hakii Y; Kuroiwa Y
    Rinsho Shinkeigaku; 2008 Sep; 48(9):666-9. PubMed ID: 19048951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
    Yeh JH; Chen WH; Chiu HC; Vincent A
    Neurology; 2004 Jun; 62(11):2131-2. PubMed ID: 15184635
    [No Abstract]   [Full Text] [Related]  

  • 9. Mantle cell lymphoma and anti-MuSK-positive Myasthenia gravis.
    Bhatt A; Farooq MU; Chang HT
    Onkologie; 2011; 34(7):382-3. PubMed ID: 21734425
    [No Abstract]   [Full Text] [Related]  

  • 10. Is "seronegative" MG explained by autoantibodies to MuSK?
    Vincent AC; McConville J; Newsom-Davis J
    Neurology; 2005 Jan; 64(2):399; author reply 399. PubMed ID: 15668461
    [No Abstract]   [Full Text] [Related]  

  • 11. [Seronegative myasthenia gravis].
    Gajdos P
    Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
    Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is "seronegative" MG explained by autoantibodies to MuSK?
    Lindstrom J
    Neurology; 2004 Jun; 62(11):1920-1. PubMed ID: 15184587
    [No Abstract]   [Full Text] [Related]  

  • 14. AChR-and MuSK-positive myasthenia gravis: Double trouble.
    Zouvelou V; Psimenou E
    J Neuroimmunol; 2020 Nov; 348():577364. PubMed ID: 32916523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis.
    Bekooij TJS; Gilhuis HJ; Dawson L; Niks EH
    J Neuromuscul Dis; 2020; 7(1):47-50. PubMed ID: 31868676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients.
    Koneczny I; Stevens JA; De Rosa A; Huda S; Huijbers MG; Saxena A; Maestri M; Lazaridis K; Zisimopoulou P; Tzartos S; Verschuuren J; van der Maarel SM; van Damme P; De Baets MH; Molenaar PC; Vincent A; Ricciardi R; Martinez-Martinez P; Losen M
    J Autoimmun; 2017 Feb; 77():104-115. PubMed ID: 27965060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vocal cord paralysis as a manifestation of myasthenia gravis with anti-MuSK antibodies.
    Jiménez Caballero PE; Fermin Marrero JA; Trigo Bragado I; Casado Naranjo I
    Neurologia; 2014 May; 29(4):253-4. PubMed ID: 23040717
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-MuSK myasthenia gravis with prolonged remission.
    Bouwyn JP; Magnier P; Bédat-Millet AL; Ahtoy P; Maltête D; Lefaucheur R
    Neuromuscul Disord; 2016 Jul; 26(7):453-4. PubMed ID: 27161384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.